<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical signs were mild, and complications were relatively rare. A total of 185 (8.7%) patients reported AEs. Of these, 117 (9.0%) received antiviral therapy and 68 (8.2%) were untreated (
 <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables 3</xref> and 
 <xref ref-type="supplementary-material" rid="sup1">4</xref>). The incidence of AEs was the highest for young children (aged &lt;5 years). Serious AEs were reported in 14 (0.7%) children, of whom 10 (0.8%) received oseltamivir treatment and 4 (0.5%) were untreated (
 <xref ref-type="supplementary-material" rid="sup1">Supplementary Tables 5</xref> and 
 <xref ref-type="supplementary-material" rid="sup1">6</xref>). Two children were admitted to the intensive care unit (ICU), one 5-month-old infant and one 8-year-old child. Both were treated with oseltamivir and recovered.
</p>
